Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
(+)-VINCRISTINE
Myelodysplastic Syndrome
Andrew E. Place, MDP2B (62)
Vorinostat
Leukemia, Myeloid, Accelerated-Phase
University of Michigan Rogel Cancer CenterP2B (62)
Vorinostat
Myelodysplastic Syndrome With Excess Blasts
National Cancer Institute (NCI)P2B (62)
Vorinostat
Chronic Myeloid Leukemia
OHSU Knight Cancer InstituteP2B (62)
Xaliplatin
Urinary Bladder Carcinoma
Arcus Biosciences, Inc.P2B (62)
Z/E 4-HYDROXY TAMOXIFEN
Ductal Breast Carcinoma In Situ
Northwestern UniversityP2B (62)
Zelquistinel
Major Depressive Disorder
Syndeio Biosciences, IncP2B (62)
Aav-Gad
Parkinson Disease
MeiraGTx, LLCP2B (61)
Acalabrutinib
B-Cell Non-Hodgkin Lymphoma
AstraZenecaP2B (61)
Acalabrutinib
Richter Transformation
Mayo ClinicP2B (61)
Adriamycin
Chronic Myeloid Leukemia
OHSU Knight Cancer InstituteP2B (61)
ALLOGENEIC HUMAN UMBILICAL CORD BLOOD
Acute Lymphoblastic Leukemia
Leland MethenyP2B (61)
all-P-ambo-3'-deoxy-P-dimethylamino-2',3'-imino-2',3'-secothymidylyl-(2’a?5’)-P,3'-dideoxy-P-dimethylamino-2',3'-imino-2',3'-secothymidylyl-(2’a?5’)-P,2',3'-trideoxy-P-dimethylamino-2',3'-imino-2',3'-secoguanylyl-(2’a?5’)-P,3'-dideoxy-P-dimethylamino-2',3'-imino-2',3'-secothymidylyl-(2'a?5')P,2',3'-trideoxy-P-dimethylamino-2',3'-imino-2',3'-secoguanylyl-(2'a?5')-P,3'-dideoxy-P-dimethylamino-2',3'-imino-2',3'-secothymidylyl-(2’a?5’)-P,2',3'-trideoxy-P-dimethylamino-2',3'-imino-2',3'-secocytidylyl-(2’a?5’)-P,3'-dideoxy-P-dimethylamino-2',3'-imino-2',3'-secothymidylyl-(2'a?5')-P,3'-dideoxy-P-dimethylamino-2',3'-imino-2',3'-secothymidylyl-(2’a?5’)-P,3'-dideoxy-P-dimethylamino-2',3'-imino-2',3'-secothymidylyl-(2'a?5')-P,2',3'-trideoxy-P-dimethylamino-2',3'-imino-2',3'-secocytidylyl-(2'a?5')-P,3'-dideoxy-P-dimethylamino-2',3'-imino-2',3'-secothymidylyl-(2'a?5')-P,3'-dideoxy-P-dimethylamino-2',3'-imino-2',3'-secothymidylyl-(2'a?5')-P,2',3'-trideoxy-P-dimethylamino-2',3'-imino-2',3'-secocytidylyl-(2'a?5')-P,3'-dideoxy-P-dimethylamino-2',3'-imino-2',3'-secothymidylyl-(2'a?5')-P,2',3'-trideoxy-P-dimethylamino-2',3'-imino-2',3'-secoguanylyl-(2'a?5')-P,3'-dideoxy-P-dimethylamino-2',3'-imino-2',3'-secothymidylyl-(2'a?5')-P,3'-dideoxy-P-dimethylamino-2',3'-imino-2',3'-secothymidylyl-(2'a?5')-P,2',3'-trideoxy-P-dimethylamino-2',3'-imino-2',3'-secoadenylyl-(2'a?5')-P,2',3'-trideoxy-P-dimethylamino-2',3'-imino-2',3'-secoguanylyl-(2'a?5')-P,2',3'-trideoxy-P-dimethylamino-2',3'-imino-2',3'-secocytidylyl-(2'a?5')-P,2',3'-trideoxy-P-dimethylamino-2',3'-imino-2',3'-secocytidylyl-(2'a?5')-P,2',3'-trideoxy-P-dimethylamino-2',3'-imino-2',3'-secoadenylyl-(2'a?5')-2',3'-trideoxy-2',3'-imino-2',3'-secocytidine
Duchenne Muscular Dystrophy
NS Pharma, Inc.P2B (61)
Anakinra
Cytokine Release Syndrome
Ann & Robert H Lurie Children's Hospital of ChicagoP2B (61)
Anti-Cd30/Cd16A Monoclonal Antibody Afm13
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Affimed GmbHP2B (61)
ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT
Acute Leukemia
Masonic Cancer Center, University of MinnesotaP2B (61)
ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
M.D. Anderson Cancer CenterP2B (61)
ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT
Hodgkins Lymphoma
Fred Hutchinson Cancer CenterP2B (61)
APOCEPT
Glioblastoma
CANbridge Life Sciences Ltd.P2B (61)
Atezolizumab
Urinary Bladder Carcinoma
National Cancer Institute (NCI)P2B (61)
Azacytidine
Diffuse Large B-Cell Lymphoma
Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityP2B (61)
Basiliximab
Acute Myeloid Leukemia
City of Hope Medical CenterP2B (61)
Bendamustine
Acute Lymphoblastic Leukemia
St. Petersburg State Pavlov Medical UniversityP2B (61)
Bendamustine
Peripheral T-Cell Lymphoma, Not Otherwise Specified
The First Affiliated Hospital of Soochow UniversityP2B (61)
Bortezomib
Myelodysplastic Syndrome
Indiana UniversityP2B (61)
Showing 1326 to 1350 of 13,155 assets
PreviousPage 54 of 527Next